Diagnosis and Management of Schizophrenic Disorders

Diagnosis and Management of Schizophrenic Disorders

March 2006 – Vol 8 – No. 1

Basic research

Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
Mark A. Geyer, PhD

Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia
Jack R. Foucher, MD; David Luck, PhD

Clinical impact of recently detected susceptibility genes for schizophrenia
Wolfgang Maier, MD; Astrid Zobel, MD; Kai-Uwe Kühn, MD

Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia
Bruno R. Souza, MSc; Renan P. Souza, BSc; Daniela V. F. Rosa, MSc; Melissa M. Guirnarães, MSc; Humberto Correa, MD; PhD; Marco A. Romano-Silva, MD; PhD

Clinical research

ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine
Johanna Krause, MD; Klaus-Henning Krause, MD; Stefan H. Dresel, MD; Christian la Fougère, MD; Manfred Ackenheil, MD

Schizophrenia in late life: emerging issues
David P. Folsom, MD; Barry D. Lebowitz, PhD; Laurie A. Lindamer, PhD; Barton W. Palmer, PhD; Thomas L. Patterson, PhD; Dilip V. Jeste, MD

Effects of disorganization on choice reaction time and visual orientation in untreated schizophrenics
Isabelle Arnado, MD, PhD; Jean-Pierre Olié, MD

A review of emotion deficits in schizophrenia
Fabien Trémeau, MD

Understanding structural brain changes in schizophrenia
Lynn E. DeLisi , MD; Kamila U. Szulc, BS; Hilary C. Bertisch, PhD; Magda Majcher , BS; Kyle Brown, BS

Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation
Bernard Lerer, MD; Ronnen H. Segman, MD

The development concept of “endogenous psychoses”
Helmut Beckmann , MD; Hermann Jakob, MD; Dieter Senitz, MD

The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia
Stephen R. Marder, MD

The German Research Network on Schizophrenia-impact on the management of schizophrenia
Wolfgang Wölwer, PhD; Anja Baumann, MA; Andreas Bechdolf, MD; Gerhard Buchkremer, MD; Heinz Häfner, MD; Birgit Janssen, MD; Joachim Klosterkötter, MD; Wolfgang Maier, MD; Hans-Jürgen Möller, MD; Stephan Ruhrmann, MD; Wolfgang Gaebel, MD

Quantitative analysis of motor disturbances in schizophrenic patients
Albert Putzhammer, MD; Helmfried E. Klein, MD

The impact of subjective well-being under neuroleptic treatment on compliance and remission
Walter de Millas, MD; Martin Lambert, MD; Dieter Naber, MD

Pharmacological aspects

Substance abuse in patients with schizophrenia
Bernadette Winklbaur, MD; Nina Ebner, MD; Gabriele Sachs, MD; Kenneth Thau, MD; Gabriele Fischer, MD

A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
Arvid Carlsson, MD, PhD; Maria L. Carlsson, PhD